j Abstract Redox signaling prior to a lethal ischemic insult is an important step in triggering the protected state in ischemic preconditioning. When the preconditioned heart is reperfused a second sequence of signal transduction events, the mediator pathway, occurs which is believed to inhibit mitochondrial permeability transition pore formation that normally destroys mitochondria in much of the reperfused tissue. Prominent among the mediator pathway's events is activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase. Recently it was found that both activation of PKC and generation of reactive oxygen species (ROS) at the time of reperfusion are required for protection in preconditioned hearts. To establish their relative order we tested whether ROS formation at reperfusion is required in hearts protected by direct activation of PKC at reperfusion. Isolated rabbit hearts were exposed to 30 min of regional ischemia and 2 h of reperfusion. Preconditioned hearts received 5 min of global ischemia and 10 min of reperfusion prior to the index ischemia. Another group of preconditioned hearts was exposed to 300 lM of the ROS scavenger N-(2-mercaptopropionyl) glycine (MPG) for 20 min starting 5 min prior to reperfusion. Infarct size was measured by triphenyltetrazolium staining. Preconditioning reduced infarct size from 36% ± 2% of the ischemic zone in control hearts to only 18 ± 2%. MPG during early reperfusion completely blocked preconditioning's protection (33 ± 3% infarction). MPG given in the same dose and schedule to nonpreconditioned hearts had no effect on infarct size. In the last group phorbol 12-myristate 13-acetate (PMA) (0.05 nM) was given to nonpreconditioned hearts from 1 min before to 5 min after reperfusion in addition to MPG administered as in the other groups. MPG did not block protection from an infusion of PMA as infarct size was only 9 ± 2% of the risk zone. We conclude that while redox signaling during the first few minutes of reperfusion is an essential component of preconditioning's protective mechanism, this step occurs upstream of PKC activation.
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Introduction
In 1997 we [2] as well as Tritto et al. [25] reported that reactive oxygen species (ROS) were involved in the triggering of ischemic preconditioning (IPC). Later it was found that ROS were generated as a result of opening of mitochondrial ATP-sensitive potassium channels (mK ATP ) and acted as second messengers in a pathway ending in activation of PKC, which triggered the preconditioned state [21] . In those studies ROS were recognized as part of the trigger pathway that preconditions the heart prior to the onset of the index ischemia. Several years ago it was discovered that IPC actually exerts its protective effect in the first minutes of reperfusion [9] presumably by inhibiting the formation of mitochondrial permeability transition pores (mPTP) [11] . Then it was found that redox signaling is part of the pathway that mediates IPC's protection at the time of reperfusion as well. Penna et al. [22] reported that ROS generation was required for ischemic postconditioning to be protective. The finding that ROS could carry a protective signal at the same time that ROS were thought to be inducing reperfusion injury was very surprising [7] . But then Hausenloy et al. [10] reported that a ROS scavenger given immediately following the index ischemia also blocked IPC's protection. These observations again illustrated similarities of the mechanisms of protection of IPC and postconditioning.
It is unknown how redox signaling acts to mediate protection at reperfusion. A number of signal transduction components have been identified in IPC's mediator pathway including phosphatidylinositol (PI) 3-kinase and extracellular signal-regulated kinase (ERK) [9] . Additionally PKC must be activated at reperfusion [10, 16, 22] and adenosine A 2b receptors must be occupied [16] . Hausenloy and colleagues [10] have speculated that the order of these components was first PKC activation followed in order by occupancy of adenosine receptors, activation of the survival kinases PI3-kinase and ERK, opening of mK ATP , and generation of ROS and finally ending with inhibition of mPTP formation. In the present study we tested that order by directly activating PKC with phorbol 12-myristate 13-acetate (PMA), which we have previously shown mimics IPC when given at reperfusion [16] in a PKC-dependent fashion [23] . If redox signaling is downstream of PKC as Hausenloy et al. [10] have proposed, then a ROS scavenger should block protection resulting from PKC activation.
Methods j Surgical preparation
All animal care satisfied published guidelines [20] and procedures were approved by institutional committees. Briefly, New Zealand White rabbits were anesthetized with pentobarbital sodium (30 mg/kg i.v.) and ventilated with 100% oxygen. The heart was exposed and a suture was passed around a coronary arterial branch. The heart was excised and perfused on a Langendorff apparatus with Krebs-Henseleit bicarbonate buffer bubbled with 95% O 2 /5% CO 2 to a pH of 7.35-7.45 at 38°C. A fluid-filled latex balloon measured pressure in the left ventricle.
j Experimental protocol
Hearts of 6 experimental groups underwent 30-min coronary branch occlusion/2-h reperfusion. Control hearts had no other intervention. IPC hearts were preconditioned with 5-min global ischemia/10-min reperfusion prior to the index ischemia. In group 3 IPC hearts received N-(2-mercaptopropionyl) glycine (MPG, 300 lM) for 20 min starting 5 min before reperfusion. In the fourth group MPG was given in the same dose and schedule to non-preconditioned hearts. In the fifth group PMA (0.05 nM) was given from 1 min before to 5 min after reperfusion, and in group 6 PMA was similarly administered in addition to MPG as in groups 3 and 4. The dose of PMA was selected empirically as one that was known to confer protection [18] ; and because that protection could be blocked by chelerythrine [16] the dependence of PMA's protective effect on PKC was assured. It should be noted that group 4, a control group of MPG alone, was not contemporary but rather was from a previous study in our laboratory [5] .
j Measurement of risk zone and infarct size At the end of the experiments the coronary artery was reoccluded, and 2-9 lm fluorescent microspheres (Microgenics Corp., Freemont, CA) were infused to demarcate the non-fluorescent risk zone. The heart was cut into 2-mm-thick slices that were incubated in 1% triphenyltetrazolium chloride to stain noninfarcted tissue. Areas of infarct and risk zone were determined by planimetry of each slice and volumes calculated. Infarction is expressed as a percentage of the region at risk.
j Statistics
Infarct sizes were compared with one-way ANOVA, and post hoc pairwise comparisons done with Student-Newman-Keuls test. P < 0.05 was considered to be significant.
Results
Hemodynamics are presented in Table 1 . There were no significant baseline group differences. Coronary occlusion caused significant decreases in left ventricular developed pressure and coronary flow in all groups. There was partial recovery following reperfusion.
Infarct size data appear in Fig. 1 . Thirty minutes of regional ischemia and 2 h of reperfusion resulted in 17.6 ± 1.7% infarction of the risk zone in IPC hearts, which was significantly smaller than 36.4 ± 1.7% infarction seen in non-preconditioned hearts (P < 0.001). When IPC hearts were reperfused in the presence of MPG, infarct size increased to 32.6 ± 3.4% of the risk zone indicating that IPC's protection had been blocked. MPG in a non-preconditioned heart had no effect on infarct size (37.0 ± 2.3% infarction). The pulse of PMA fully protected the hearts (6.8 ± 1.0% infarction) and MPG did not block PMA's protection as infarct size was only 9.2 ± 1.5% of the risk zone. Interestingly infarct size in the two PMA groups was significantly smaller than that in the IPC group (P < 0.002).
Discussion
We were able to confirm the observation of Hausenloy et al. [10] that ROS production early in reperfusion is required for IPC's protection in our rabbit model. Our data also indicate that the protection from a direct PKC activator is independent of ROS production suggesting that the ROS step occurs upstream of the PKC step. Through the use of inhibitors PKC activity early in reperfusion has been shown to be required for protection against infarction from both IPC [10, 16] and postconditioning [22, 23] . Furthermore, the direct PKC activator PMA given at reperfusion mimics IPC's protection [16, 23] and this protection is blocked by chelerythrine verifying that PMA protected in a PKC-dependent manner [23] . Abbreviations: CF = coronary flow; DP = left ventricular developed pressure; IPC = ischemic preconditioning; MPG = N-(2-mercaptopropionyl) glycine; PMA = phorbol 12-myristate 13-acetate a Hemodynamics measured 2 min after the preconditioning ischemia in IPC, after 2 min of PMG infusion in IPC + MPG, and after 1 min of PMA infusion in PMA and PMA + MPG Statistical significance of difference between baseline and other time points: *P < 0.001, **P < 0.01, ***P < 0.05 Our previous data indicate that the adenosine A 2b receptor resides downstream of PKC in the mediator pathway because at reperfusion an A 2b receptor antagonist blocks protection from PMA but the PKC blocker chelerythrine does not block protection from an A 2b agonist [16, 23] . We found that PKC activity lowers the threshold for A 2b agonists to activate the survival kinases suggesting that in the IPC heart the increased sensitivity allows endogenous adenosine to activate protective signaling through the normally low-affinity A 2b receptors [16] . Accordingly we were able to demonstrate that PI3-kinase and ERK activity is dependent on population of adenosine receptors since receptor inhibition at reperfusion blocked survival kinase activation in IPC hearts [24] . Also, protection from PMA at reperfusion could be blocked by the PI3-kinase blocker wortmannin [23] . Taken together this information now allows us to propose a revised arrangement for the sequence of signal transduction elements for the mediator pathway. In our new order we start with ROS followed in sequence by PKC, A 2b receptors, and survival kinases leading to inhibition of mPTP (Fig. 2) .
Costa et al. [6] found that mK ATP openers protected isolated mitochondria from Ca ++ -induced mPTP formation. That protection was both ROS-and PKC-sensitive. Furthermore they could show that ROS protected by activation of PKC. Because these were isolated mitochondria they concluded that once the mK ATP opened all of the signal transduction elements required to inhibit mPTP formation were present within the mitochondria. The present findings are in agreement with some of the observations made by Costa et al. [6] Protection from PMA does not require ROS and is therefore downstream of the ROS signal. However, PMA's protection requires both adenosine receptor occupancy as well as PI3-kinase activation [23] indicating that in a whole heart protection from a direct PKC activator still requires signals that arise from outside the mitochondria. We have no explanation for this apparent discrepancy.
The protection from PMA was significantly more potent than that from IPC. While IPC is thought to selectively activate a single isoform of PKC (perhaps e), PMA is not selective for any isoform and may have activated additional isoforms to provide more protection. Alternatively the single IPC protocol we used may not have fully preconditioned our hearts. PMA also reduced coronary flow and contractility. The reduced coronary flow could have ischemically preconditioned the hearts, but if that were the case MPG should have blocked it. Although PMA was present in the perfusate for about a minute before reperfusion it would not have appreciably entered the ischemic tissue until the artery was reperfused because of sparse collateralization in the rabbit heart.
Our data do not provide information about the location of the mK ATP channel in the signaling cascade. In a recent study Gross et al. [8] gave the mK ATP opener BMS-191095 just prior to reperfusion in openchest rats and were able to mimic IPC's anti-infarct effect. Moreover they could block BMS-191095's protection with the PI3-kinase inhibitor wortmannin thus putting mK ATP ahead of PI3-kinase. The most likely place for mK ATP to reside would be ahead of the ROS step. IPC's trigger pathway has been extensively studied and in that pathway we [15, 21] and others [1] have found that potassium entry from mK ATP opening results in ROS production by the mitochondria. Thus the mediator pathway could simply look like IPC's trigger pathway with mK ATP opening resulting in ROS production. This suggestion does not fit all of the data, however. In a cardiomyocyte model Lebuffe et al. [17] found that they could protect cells against simulated ischemia with either PMA or hydrogen peroxide and that the mK ATP blocker 5-hydroxydecanoate blocked protection from both. That would put the mK ATP channel downstream of ROS and PKC. Juhaszova et al. [13] also were confronted with discrepant data about the location of mK ATP in their flowchart and decided that the data warranted a dual location, one upstream of the ROS step and another downstream near mPTP, and we have also done that in Fig 2. How do we explain the apparent coexistence of a protective free radical signal and the very injurious free radical burst that is supposed to occur in the reperfused heart [3] ? Most observers have noted that IPC does not increase but actually reduces overall ROS production in reperfused hearts [26] . The most likely explanation is that the ROS signal is carried by one specific radical species and/or in one intracellular compartment. MPG obviously is able to scavenge the radical species that signals the protection. MPG is a very selective scavenger for hydroxyl radical and peroxynitrite and does not affect superoxide or hydrogen peroxide [4] . We also have unpublished measurements showing that MPG does not scavenge nitric oxide. In addition MPG reportedly concentrates 500-fold in mitochondria making it highly effective against mitochondria-generated ROS [19] . Protection from preconditioning with a ROS generator is known to be PKC-dependent [2, 25] , and indeed Korichneva et al. [14] found that ROS could directly activate PKC in vitro by reacting with its thiol groups. Thus hydroxyl radical made by mitochondria could directly activate local PKC independent of the other injurious ROS species generated during reperfusion. The simplest explanation for our observation is that hydroxyl radical made by the IPC heart's mitochondria early in reperfusion protects by activating PKC. It is currently unknown why that activation fails to occur in the non-IPC heart.
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